A citation-based method for searching scientific literature

Jennifer L Beebe-Dimmer, Ashley L Kapron, Alison M Fraser, Ken R Smith, Kathleen A Cooney. J Clin Oncol 2020
Times Cited: 8







List of co-cited articles
38 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
Minh-Phuong Huynh-Le, Chun Chieh Fan, Roshan Karunamuni, Eleanor I Walsh, Emma L Turner, J Athene Lane, Richard M Martin, David E Neal, Jenny L Donovan, Freddie C Hamdy,[...]. Cancer Epidemiol Biomarkers Prev 2020
13
37

Germline Mutations in ATM and BRCA1/2 Distinguish Risk for Lethal and Indolent Prostate Cancer and are Associated with Early Age at Death.
Rong Na, S Lilly Zheng, Misop Han, Hongjie Yu, Deke Jiang, Sameep Shah, Charles M Ewing, Liti Zhang, Kristian Novakovic, Jacqueline Petkewicz,[...]. Eur Urol 2017
156
37

Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.
Colin C Pritchard, Joaquin Mateo, Michael F Walsh, Navonil De Sarkar, Wassim Abida, Himisha Beltran, Andrea Garofalo, Roman Gulati, Suzanne Carreira, Rosalind Eeles,[...]. N Engl J Med 2016
662
37

Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer.
H Ballentine Carter, Brian Helfand, Mufaddal Mamawala, Yishuo Wu, Patricia Landis, Hongjie Yu, Kathleen Wiley, Rong Na, Zhuqing Shi, Jacqueline Petkewicz,[...]. Eur Urol 2019
53
37

Germline mutations in HOXB13 and prostate-cancer risk.
Charles M Ewing, Anna M Ray, Ethan M Lange, Kimberly A Zuhlke, Christiane M Robbins, Waibhav D Tembe, Kathleen E Wiley, Sarah D Isaacs, Dorhyun Johng, Yunfei Wang,[...]. N Engl J Med 2012
358
37

Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019.
Veda N Giri, Karen E Knudsen, William K Kelly, Heather H Cheng, Kathleen A Cooney, Michael S Cookson, William Dahut, Scott Weissman, Howard R Soule, Daniel P Petrylak,[...]. J Clin Oncol 2020
51
37

Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines.
Piper Nicolosi, Elisa Ledet, Shan Yang, Scott Michalski, Brandy Freschi, Erin O'Leary, Edward D Esplin, Robert L Nussbaum, Oliver Sartor. JAMA Oncol 2019
82
37


Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
Marco Matejcic, Edward J Saunders, Tokhir Dadaev, Mark N Brook, Kan Wang, Xin Sheng, Ali Amin Al Olama, Fredrick R Schumacher, Sue A Ingles, Koveela Govindasami,[...]. Nat Commun 2018
24
25

Analysis of the Prevalence of Microsatellite Instability in Prostate Cancer and Response to Immune Checkpoint Blockade.
Wassim Abida, Michael L Cheng, Joshua Armenia, Sumit Middha, Karen A Autio, Hebert Alberto Vargas, Dana Rathkopf, Michael J Morris, Daniel C Danila, Susan F Slovin,[...]. JAMA Oncol 2019
184
25


Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.
Veda N Giri, Karen E Knudsen, William K Kelly, Wassim Abida, Gerald L Andriole, Chris H Bangma, Justin E Bekelman, Mitchell C Benson, Amie Blanco, Arthur Burnett,[...]. J Clin Oncol 2018
93
25

Concordance of tumor differentiation among brothers with prostate cancer.
K Fredrik Jansson, Olof Akre, Hans Garmo, Anna Bill-Axelson, Jan Adolfsson, Pär Stattin, Ola Bratt. Eur Urol 2012
17
25

Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer.
Burcu F Darst, Tokhir Dadaev, Ed Saunders, Xin Sheng, Peggy Wan, Loreall Pooler, Lucy Y Xia, Stephen Chanock, Sonja I Berndt, Susan M Gapstur,[...]. J Natl Cancer Inst 2021
10
25

Concordance of survival in family members with prostate cancer.
Kari Hemminki, Jianguang Ji, Asta Försti, Jan Sundquist, Per Lenner. J Clin Oncol 2008
45
25

Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
Tokhir Dadaev, Edward J Saunders, Paul J Newcombe, Ezequiel Anokian, Daniel A Leongamornlert, Mark N Brook, Clara Cieza-Borrella, Martina Mijuskovic, Sarah Wakerell, Ali Amin Al Olama,[...]. Nat Commun 2018
47
25

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
25

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).
Jianfeng Xu, Ethan M Lange, Lingyi Lu, Siqun L Zheng, Zhong Wang, Stephen N Thibodeau, Lisa A Cannon-Albright, Craig C Teerlink, Nicola J Camp, Anna M Johnson,[...]. Hum Genet 2013
122
25

Germline and Somatic Mutations in Prostate Cancer for the Clinician.
Heather H Cheng, Alexandra O Sokolova, Edward M Schaeffer, Eric J Small, Celestia S Higano. J Natl Compr Canc Netw 2019
28
25

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
201
25

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Georgios N Tsaousis, Eirini Papadopoulou, Angela Apessos, Konstantinos Agiannitopoulos, Georgia Pepe, Stavroula Kampouri, Nikolaos Diamantopoulos, Theofanis Floros, Rodoniki Iosifidou, Ourania Katopodi,[...]. BMC Cancer 2019
20
25

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.
Elena Castro, Chee Goh, David Olmos, Ed Saunders, Daniel Leongamornlert, Malgorzata Tymrakiewicz, Nadiya Mahmud, Tokhir Dadaev, Koveela Govindasami, Michelle Guy,[...]. J Clin Oncol 2013
375
25

Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study.
Tommy Nyberg, Debra Frost, Daniel Barrowdale, D Gareth Evans, Elizabeth Bancroft, Julian Adlard, Munaza Ahmed, Julian Barwell, Angela F Brady, Carole Brewer,[...]. Eur Urol 2020
30
25

The heritability of prostate cancer in the Nordic Twin Study of Cancer.
Jacob B Hjelmborg, Thomas Scheike, Klaus Holst, Axel Skytthe, Kathryn L Penney, Rebecca E Graff, Eero Pukkala, Kaare Christensen, Hans-Olov Adami, Niels V Holm,[...]. Cancer Epidemiol Biomarkers Prev 2014
101
25

Hereditary prostate cancer as a feature of Lynch syndrome.
Christina M Bauer, Anna M Ray, Bronwen A Halstead-Nussloch, Robert G Dekker, Victoria M Raymond, Stephen B Gruber, Kathleen A Cooney. Fam Cancer 2011
42
25

HOXB13 G84E mutation in Finland: population-based analysis of prostate, breast, and colorectal cancer risk.
Virpi H Laitinen, Tiina Wahlfors, Leena Saaristo, Tommi Rantapero, Liisa M Pelttari, Outi Kilpivaara, Satu-Leena Laasanen, Anne Kallioniemi, Heli Nevanlinna, Lauri Aaltonen,[...]. Cancer Epidemiol Biomarkers Prev 2013
59
25

Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls.
Yukihide Momozawa, Yusuke Iwasaki, Makoto Hirata, Xiaoxi Liu, Yoichiro Kamatani, Atsushi Takahashi, Kokichi Sugano, Teruhiko Yoshida, Yoshinori Murakami, Koichi Matsuda,[...]. J Natl Cancer Inst 2020
21
25

Family history and prostate cancer risk in a population-based cohort of Iowa men.
J R Cerhan, A S Parker, S D Putnam, B C Chiu, C F Lynch, M B Cohen, J C Torner, K P Cantor. Cancer Epidemiol Biomarkers Prev 1999
88
25

Integrative clinical genomics of advanced prostate cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
25

Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
Tyler M Seibert, Chun Chieh Fan, Yunpeng Wang, Verena Zuber, Roshan Karunamuni, J Kellogg Parsons, Rosalind A Eeles, Douglas F Easton, ZSofia Kote-Jarai, Ali Amin Al Olama,[...]. BMJ 2018
67
25

Prostate cancer incidence in males with Lynch syndrome.
Sigurdis Haraldsdottir, Heather Hampel, Lai Wei, Christina Wu, Wendy Frankel, Tanios Bekaii-Saab, Albert de la Chapelle, Richard M Goldberg. Genet Med 2014
62
25

Germline genetic variants in men with prostate cancer and one or more additional cancers.
Patrick G Pilié, Anna M Johnson, Kristen L Hanson, Megan E Dayno, Ashley L Kapron, Elena M Stoffel, Kathleen A Cooney. Cancer 2017
27
25

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
Kasmintan A Schrader, Donavan T Cheng, Vijai Joseph, Meera Prasad, Michael Walsh, Ahmet Zehir, Ai Ni, Tinu Thomas, Ryma Benayed, Asad Ashraf,[...]. JAMA Oncol 2016
164
25

Determining the frequency of pathogenic germline variants from exome sequencing in patients with castrate-resistant prostate cancer.
Steven N Hart, Marissa S Ellingson, Kim Schahl, Peter T Vedell, Rachel E Carlson, Jason P Sinnwell, Poulami Barman, Hugues Sicotte, Jeanette E Eckel-Passow, Liguo Wang,[...]. BMJ Open 2016
22
25

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein, N V Holm, P K Verkasalo, A Iliadou, J Kaprio, M Koskenvuo, E Pukkala, A Skytthe, K Hemminki. N Engl J Med 2000
25

NBS1 is a prostate cancer susceptibility gene.
C Cybulski, B Górski, T Debniak, B Gliniewicz, M Mierzejewski, B Masojć, A Jakubowska, J Matyjasik, E Złowocka, A Sikorski,[...]. Cancer Res 2004
112
25

Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.
Z Kote-Jarai, C Mikropoulos, D A Leongamornlert, T Dadaev, M Tymrakiewicz, E J Saunders, M Jones, S Jugurnauth-Little, K Govindasami, M Guy,[...]. Ann Oncol 2015
53
25

Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
254
25

SPINK1 protein expression and prostate cancer progression.
Richard Flavin, Andreas Pettersson, Whitney K Hendrickson, Michelangelo Fiorentino, Stephen Finn, Lauren Kunz, Gregory L Judson, Rosina Lis, Dyane Bailey, Christopher Fiore,[...]. Clin Cancer Res 2014
47
12

SPOP mutations in prostate cancer across demographically diverse patient cohorts.
Mirjam Blattner, Daniel J Lee, Catherine O'Reilly, Kyung Park, Theresa Y MacDonald, Francesca Khani, Kevin R Turner, Ya-Lin Chiu, Peter J Wild, Igor Dolgalev,[...]. Neoplasia 2014
89
12


Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor.
Philip A Watson, Yinan F Chen, Minna D Balbas, John Wongvipat, Nicholas D Socci, Agnes Viale, Kwanghee Kim, Charles L Sawyers. Proc Natl Acad Sci U S A 2010
450
12

TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favorable prognosis.
Outi R Saramäki, Anna E Harjula, Paula M Martikainen, Robert L Vessella, Teuvo L J Tammela, Tapio Visakorpi. Clin Cancer Res 2008
185
12

Cumulative Evidence for Relationships Between 8q24 Variants and Prostate Cancer.
Yu Tong, Tao Yu, Shiping Li, Fengyan Zhao, Junjie Ying, Yi Qu, Dezhi Mu. Front Physiol 2018
4
25

Genetic susceptibility to prostate cancer.
Géraldine Cancel-Tassin, Olivier Cussenot. BJU Int 2005
16
12

Cancer Statistics, 2017.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2017
12

Effects of replacing PSA with Stockholm3 for diagnosis of clinically significant prostate cancer in a healthcare system - the Stavanger experience.
Eirik Viste, Cathrine Alvaer Vinje, Torgeir Gilje Lid, Svein Skeie, Øystein Evjen-Olsen, Tobias Nordström, Olav Thorsen, Bjørnar Gilje, Emiel A M Janssen, Svein R Kjosavik. Scand J Prim Health Care 2020
6
16

Integrative clinical transcriptome analysis reveals TMPRSS2-ERG dependency of prognostic biomarkers in prostate adenocarcinoma.
Julia S Gerke, Martin F Orth, Yuri Tolkach, Laura Romero-Pérez, Fabienne S Wehweck, Stefanie Stein, Julian Musa, Maximilian M L Knott, Tilman L B Hölting, Jing Li,[...]. Int J Cancer 2020
7
14

Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate Cancer.
Arun A Azad, Stanislav V Volik, Alexander W Wyatt, Anne Haegert, Stephane Le Bihan, Robert H Bell, Shawn A Anderson, Brian McConeghy, Robert Shukin, Jenny Bazov,[...]. Clin Cancer Res 2015
295
12

Integrative Clinical Genomics of Advanced Prostate Cancer.
Dan Robinson, Eliezer M Van Allen, Yi-Mi Wu, Nikolaus Schultz, Robert J Lonigro, Juan-Miguel Mosquera, Bruce Montgomery, Mary-Ellen Taplin, Colin C Pritchard, Gerhardt Attard,[...]. Cell 2015
244
12


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.